Fair value · ARGENX SE (ARGNF) · updated 2026-09-03 · from annual report FY2025
Everything below is unaffected: the filed statements, the filing they came from, and ARGNF’s growth history are all as reported.
annual report FY2025 · fiscal year ended 2025-12-31 · filed 2026-03-19 · accession 0001697862-26-000032
Open this filing on sec.govAt least two methods need a usable value to draw a range with these inputs.
No preset range for this company yet.
The two ranges are identical because every input sits on a preset.
We don’t tell you what ARGNF is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has ARGNF’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.
Discounted cash flow
N/A
Financials are filed in EUR; our prices are in USD, so these methods need a conversion we do not yet publish.
Preset inputs — revenue-driven DCF from the latest filing
Implied by today’s price
Financials are filed in EUR; our prices are in USD, so these methods need a conversion we do not yet publish.
Not solvable from the price — Financials are filed in EUR; our prices are in USD, so these methods need a conversion we do not yet publish. Showing preset inputs.
This method has no key input to read out of the price. The others below do, and you set them yourself: the growth matrix shows what ARGNF has actually filed, and the AI chat will reason it through with you.
Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.
Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.
How long stage-1 growth lasts.
Slower growth after stage 1, before the terminal phase.
Growth forever after the two stages. Above ~3% is rarely justified.
The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.
| Year | Stage | FCF | Present value |
|---|---|---|---|
| 1 | Stage 1 | $1,028M | $920M |
| 2 | Stage 1 | $1,556M | $1,248M |
| 3 | Stage 1 | $2,356M | $1,692M |
| 4 | Stage 1 | $3,568M | $2,293M |
| 5 | Stage 1 | $5,401M | $3,109M |
| 6 | Stage 2 | $6,028M | $3,107M |
| 7 | Stage 2 | $6,727M | $3,105M |
| 8 | Stage 2 | $7,507M | $3,102M |
| 9 | Stage 2 | $8,378M | $3,100M |
| 10 | Stage 2 | $9,350M | $3,098M |
Inputs from the filing
Financials are filed in EUR; our prices are in USD, so these methods need a conversion we do not yet publish.
annual report FY2025 · period ended 2025-12-31 · filed 2026-03-19 · accession 0001697862-26-000032 · sec.gov
Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for ARGNF